Markus Angerer
Papers
2
Total Citations
11
H-Index
2
About
Markus Angerer is a pioneering surgeon whose work is reshaping the surgical management of testicular cancer through the application of robotic technology. His primary research focuses on the feasibility, safety, and technical refinement of robotic retroperitoneal lymph node dissection (R-RPLND), a complex procedure traditionally associated with high morbidity. Angerer’s major contributions include demonstrating the oncological safety of R-RPLND in a single-center study, providing critical evidence that a minimally invasive approach can match the gold-standard open surgery without compromising cancer control. He has further advanced the field by meticulously analyzing the learning curve for a single surgeon, offering a valuable roadmap for other institutions adopting this technique. While his most-cited papers are recent (2025), their rapid accumulation of citations—7 and 4 respectively—signals a strong and immediate impact within the urologic oncology community. Angerer’s work is notable for its focus on reducing patient morbidity while maintaining rigorous oncological principles, positioning him as a key figure in the transition toward less invasive, robot-assisted treatments for testicular cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2